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Abstract: The aim of this paper is to apply the hermeneutic approach to social 
imaginaries of science and technology. Special attention will be given to discuss how 
the techno-scientific system intends to face poverty, although the system focuses to a 
different direction, which is a growing inter-penetration with the economic system. 
The techno-scientific system, as well as its politics, sets aside poor people. In such a 
context, the scientific-technologic gap continues to grow, generating gradually two 
different paces of international development. Factors like the cyborgization, 
robotization, the development of ITCs, etc., have an impact into the poorest regions, 
ending up into situations of technologic-scientific neo-colonialism. In spite of 
peripheral states efforts, the possible development of these regions is an always faced 
and never overcome challenge. Transformations of the scientific-technologic system, 
which are more and more scientifically and technologically dependent every day, 
constitute as a gap.  
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Nowadays, the possibilities for human auto-transformation through the development of 
(bio)technologies are increasing (Coca and Valero 2010). Thinking the human being as a cyborg is less 
of a sciences fiction scenery and more of the daily world. The era or paradigm where we are immersed is 
not free from great controversies and challenges. One of which, and perhaps, the main one, is that of the 
possibilities of (bio) technological human self-transformation. As a consequence, the human being starts 
to be considered as a cyborg, which implies many fields: ethical, political, anthropological, 
philosophical, social, etc. This new way of understanding what it means to be human is based upon the 
development of a conjunction of bio-technologic social imaginaries. In this paper, our premise is the 
growing inter-penetration between the techno-scientific and the economic systems and we study in depth 
the social imaginaries which are formed based on it. This analysis points as well to the north-south gap, 
implemented upon the social imaginaries which take part on this inter-systemic interaction. It must be 
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taken into account that this paper is centered, specifically on the Spanish-speaking region, with more 
emphasis on Spain. 
Different techno-scientific agents are required to carry out research projects, where both the university 
and the enterprise share common goals. Thus, economic-business factors that condition, alter, and 
influence the techno-scientific system have to be considered to understand the development of current 
techno-science. At the same time, we focus on the development of the biotechnology sector in order to be 
aware of the techno-scientific system. We must point out that the process of patenting products is a basic 
process in enterprises with a technologic base; it allows to protect the results of an activity previously 
known as R&D (research and development) and currently known as R&D&i (research and development 
and innovation). This fact creates a negative social protection problem among the social system sectors, 
which value the business system negatively. Furthermore, patents play a key role in company's business 
strategy. In fact, some companies (according to the market, the economic potential, the developed 
product and their competitors' current situation) can end up deciding that the best option to protect their 
inventions is hiding and being secretive about them (Barrete, 2009). 
When studying the current development of patents in Iberian America, the team coordinated by 
Barrete (2009) focused on the data coming from the World Intellectual Property Organization (WIPO), 
the United States Patent and Trademark Office (USPTO) and the European Patent Office (EPO). 
Data coming from the WIPO show that during the two-year period of 2000-2001 there was an 
important increase of patents, from 7,989 to 10,827, that is, an increase of 29% during that period 
regarding the data of 2000. The number of patents registered in 2001 stayed the same the following year 
and it started to decrease after 2002. Oddly, in 2006 there were fewer patents than in 2000 (less than 
8,000). In 2007, the figures continued to drop. However, in 2008 the tendency changed dramatically, 
reaching a similar number to that of 2005—8,763 patents. 
  
 
Source: Barrete, 2009. 
Figure 1:  TOTAL PATENTS GRANTED IN BIOTECHNOLOGY (WIPO, USPTO, EPO) 
 
According to the USPTO, the number of patents registered in 2000 was about 7,000, reaching almost 
8,000 in 2001 and then decreasing constantly until 2005. Later, in 2006 the figures were similar to those 
Juan R. Coca; Jesús A. Valero Matas; Francesca Randazzo / Studies in Sociology of 
Science Vol.1 No.2 2010  
  32
in 2000 and they stayed more or less constant until 2007. They finally dropped the following year to 
6,000 patents. 
The data coming from the EPO differ from that coming from other sources. In fact, the number of 
patents registered for the period 2000-2008 increased basically every single year. However, the chart 
shows that this rise was moderate in the two-year period of 2006-2008. But if we only consider the 
Iberian American regions, we can see that Spain was the country with the largest number of patents 
compared to the rest of countries of this macro-region. In fact, over the period of 2000-2008 the number 
of registered patents (according to the holder of them) was 547 for Spain, followed by 104 in Brazil, 61 
in Portugal and Cuba, 57 in Mexico, 21 in Argentina, 13 in Colombia, 11 in Chile, whereas the rest were 
below 10. 
Data shows that Spain is the Iberian American country with the largest number of patents over the last 
few years. We can use this as an example to comprehend the guidelines of progress and development of 
the biotechnological sector. In fact, according to Barrete, the number of patents held by Spain reached 
60% of all those developed in Iberian America. Furthermore, biotechnological patents were concentrated 
in the five first countries which produce biotechnological patents, reaching 95% of the total production 
of Iberian America (Barrete, 2009).  
 
Source: Barrete (2009). 
Figure 2:  IBERIAN AMERICAN PATENTS IN BIOTECHNOLOGY (WIPO) AS FOR THE 
COUNTRY OF THE HOLDER 
 
As we know, one of the more developed biotechnological sectors is genetically modified crops. In this 
sense, over the period ranging from year 1996 to 2007, there has been a constant and continued increase 
of the world surface used for these kind of crops (James, 2007). On the other hand, in 2007, the number 
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of countries which produced this type of biotechnological crops reached 23, 12 of which were 
impoverished, while 11 were industrialized (James, 2007). This shows us that unfavorable regions see a 
possibility to try to get out of their economically difficult states through the production of 
biotechnological organisms. 
 
Table 1:  World surface cultivated with agri-biotechnological products in 2007 
Rank País Surface (millions 
of hectares) 
Type of crop 
1 USA * 57.7 Soy, corn, cotton, pumpkin, papaya, colza and alfalfa
2 Argentina * 19.1 Soy, corn and cotton 
3 Brazil * 15.0 Soy and cotton 
4 Canada * 7.0 Colza, corn and soy 
5 India * 6.2 Cotton 
6 China * 3.8 Cotton, tomato, poplar, petunia, papaya and sweet 
pepper 
7 Paraguay * 2.6 Soy 
8 South Africa * 1.8 Corn, soy and cotton 
9 Uruguay * 0.5 Soy and corn 
10 Philippines * 0.3 Corn 
11 Australia * 0.1 Cotton 
12 Spain * 0.1 Corn 
13 Mexico * 0.1 Cotton and soy 
14 Colombia <0.1 Cotton and carnation 
15 Chile <0.1 Corn, soy and colza 
16 France <0.1 Corn 
17 Honduras <0.1 Corn 
18 Czech Republic <0.1 Corn 
19 Portugal <0.1 Corn 
20 Germany <0.1 Corn 
21 Slovakia <0.1 Corn 
22 Rumania <0.1 Corn 
23 Poland <0.1 Corn 
* Biotechnological mega-countries which grow at least 50,000 hectares of genetically modified crops. 
Source: Clive James (2007). 
 
As we can see, the USA is the world's number one producer of genetically modified organisms, with a 
production which amounts to 50% of the total amount of GMOs (genetically modified organisms). Thus, 
the USA has a leading role —according to the description of international relations based on the 
center/periphery code— in the center of the biotechnological system based on the production of GMOs, 
as well as according to the levels of patents developed. However, certain countries, such as Argentina 
and Brazil, are gradually increasing their crop surfaces to reach relatively wide levels after a positive 
assessment of the economic and social possibilities that could be generated by these biotechnological 
devices. At the same time, according to James (2007), the forecast for year 2015 is that both the number 
of agri-biotechnological countries and the crops and hectares will be duplicated. In fact, countries such 
as Burkina Faso and Egypt are the next in line to develop GMOs; Vietnam may also be included among 
them. All this will mean that the number of future GMO farmers will reach a total of 100 million. 
Regarding the Iberian American region, Spain is the state with the most biotechnological production, 
if we measure the data in terms of patents, followed distantly by Brazil. In this sense, according to the 
report Biotechnology in Iberian America, there is a lack of private sector dynamism since the main 
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biotechnological patent holders are Spanish. In fact, nine out of ten of the main holders are Spanish, 
whereas the rest are of Cuban origin. At the same time, among the Spanish holders, the CSIC (Spanish 
National Research Council) is the main holder by far. For this reason, just looking at the biotechnological 
economic system in Spain is enough to understand the situation, with the sole exception of the data 
shown above. 
On the other hand, the report Relevance of Biotechnology in Spain 2007 carried out by the ‘Fundación 
Genoma España’, shows the data of production of technological enterprises in Spain. This information is 
important because it gives us an idea of the biotechnological sector evolution in an economic-business 
context. 
 
Source: Garcés, F.; Montero, J. and Vega, M. (2007). 
Figure 3:  Evolution of the number of spin-off created following Spanish universities 
 
In this sense, over the period 2000-2006, there has been a remarkable increase in the number of 
biotechnological enterprises created in Spanish universities. In fact, there were zero enterprises in year 
2000, but in 2006 there were 48. After the phase 2002-2003 we can observe the tendency of a constant 
increase in the creation of spin-off (technological enterprises). In fact, 4 corporations were created in 
year 2002, whereas the increase was of 10 new enterprises in 2003, 12 in 2004, 10 in 2005 and, finally, 
12 in 2006. This shows us that the initial pattern started in Spanish universities—which can also be 
generalized to higher education centers in Latin America—where they try to cause research groups to 
become the seeds of future enterprises. For this reason, the current techno-scientific system tries to teach 
and make the new techno-scientific students into future entrepreneurs. The education system becomes a 
transmission center between the new co-evolutionary process, the techno-scientific system and the 
economic-business system. 
Regarding the main biotechnological products of Latin America, the Spanish National Statistics 
Institute (INE) shows that, in year 2007, the total number of enterprises that developed biotechnology to 
a great or lesser extent was 764. However, not all of them were involved in innovative creation, an 
activity which generates new applications and knowledge. Therefore, the number of enterprises involved 
R&D in 2007 was 561, most of them with less than 250 employees. On the other hand, the number of 
corporations that use biotechnology either mainly or exclusively is 257, whereas those which use 
biotechnology secondarily are 179. Of all Spanish enterprises, 257 (33.6%) are involved in 
biotechnological activities mainly and/or exclusively; whereas 179 (23.4%) have biotechnology as their 
secondary business activity. Finally, for 328 companies (43%) biotechnology is a key, but not primary, 
production activity. 
This data series about the situation of biotechnological enterprises in Spain illustrates the increasing 
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importance of this activity in the development of the Spanish economic-business system. In fact, over the 
last few years, biotechnology (in the broader sense) is, together with information and communication 
technologies, one of the main pillars of the so-called “new” production system. The development of the 
techno-scientific energy sector has also been acquiring importance over the last few years; for this reason, 
it has become another basic economic-business sector. However, some of the breakthroughs coming 
from this sector involve biotechnological developments. For example, progress generated after the 
studies and research on third and fourth generation bio-fuel, production of GMOs to obtain biomass or 
oils to obtain bio-fuel, etc. 
Table 2:  Use of biotechnology by activity sectors, main variables and size of company (2007). 
 
Unit: millions of Euros 
 < 250 employees 
250 and 
more 
employees  
Total 
2007 
COMPANIES    
Companies active in biotechnology (Bt) 691  73  764  
Companies active in R&D in Bt  506  55  561  
Companies classified in accordance with the Bt they generate: 
Genetic Code 36  38  36  
Companies classified in accordance with the Bt they generate: 
Functional units 33  38  34  
Companies classified in accordance with the Bt they generate: 
Cell and tissue culture and engineering  32  44  33  
Companies classified in accordance with the Bt they generate:  
Bio-processes 48  52  48  
Companies classified in accordance with the Bt they generate: 
Sub-cellular organisms 14  19  14  
Companies classified in accordance with the Bt they generate: 
Other 20  10  19  
Companies where Bt activities are: main and/or exclusive 238  19  257  
Companies where Bt activities are: a second business line 163  16  179  
Companies where Bt activities are: a necessary tool for 
production  290  38  328  
Companies classified according to the area(s) of final 
application of the use of Bt: Human health  43  48  43  
Companies classified according to the area(s) of final 
application of the use of Bt: animal and aquaculture 21  14  21  
Companies classified according to the area(s) of final 
application of the use of Bt: Food  37  33  37  
Companies classified according to the area(s) of final 
application of the use of Bt: Agriculture and forest production 21  12  20  
Companies classified according to the area(s) of final 
application of the use of Bt: Environment 20  15  19  
Companies classified according to the area(s) of final 
application of the use of Bt: Industry 13  5  12  
Source: Spanish National Statistics Institute, INE (http://www.ines.es) 
 
Therefore, from an economic-business perspective, the relevance of the biotechnological sector is 
increasing relative to other sectors, although the economic-business development of this new technology 
in Iberian American States is clearly inferior compared to the USA's development. However, there is a 
widespread institutional consideration that the biotechnological development will bring more benefits 
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than damages. For this reason, countries such as Argentina, Brazil, Paraguay and Uruguay have decided 
production is their best bet, and are among the 10 top-producing regions of ago-biotechnological devices 
(as we see in the above data). The data, on the other hand, does not show a correlation with an increase of 
patents coming from these countries; this means that these regions are becoming sources of 
biotechnological material but are still dependent on the necessary development tools as well as the 
development of new biotechnological varieties.  
All this lead us to assert that there is a current Social Imaginary (SI) which we will name the 
development/underdevelopment SI. With this name we try to underline the discourse —positive or 
negative—of the influence of biotechnology in the world's impoverished regions. This SI leads to a 
certain discourse where, on the one hand, there are those who assert that developing these 
biotechnological devices will increase food, economic and social security in those States. The following 
are clear examples found on the Internet: 
 “The report [Biotechnology for Europe] demonstrates that biotechnological applications for 
the agricultural food sector have improved production efficiency and food safety 
(www.consumer.es 26 April 2007)” 
 “According to the FAO report, in the next 30 years about two billion people will depend on 
agriculture; thus, it will be necessary to develop technologies that combine aims such as 
increasing the yield, protecting the environment, responding to customers’ worries regarding 
food quality and safety, promoting rural means of subsistence, and food safety for the poorest 
communities. The FAO insists that biotechnology should complement traditional agriculture 
technologies because they think that biotechnology can accelerate the conventional 
improvement programs and reach solutions when conventional technologies fail” 
(www.consumer.es 18 May 2004). 
 
On the other hand, there are those who assert the opposite, that is, a greater insecurity and dependence 
of these regions: 
“Developing countries, particularly those with low incomes, reject this type of food because 
most of them are unsure about said food's benefits and safety and are afraid of depending on 
multinational corporations and losing opportunities to sell in the European market” 
(www.consumer.es 29 October 2007). 
 
We can construct three binary codes which are quasi-synonymous: humanitarianism/ colonization, 
future/past, and innovation/tradition. In this discourse of the SI of development/ underdevelopment, the 
need to acquire new bio-technologies for humanitarian progress as an innovative and positive future for 
human development is demonstrated. On the other hand, we see the negative-outcome code: 
colonization, past, and tradition—it is a smaller concern, as it simply looks at the discursive appendix, 
which argues to reject GMOs. Therefore, the underdevelopment, SI was once open to the 
economic-business context, promoting the myth of the pacifying market (Sánchez Capdequí, 2003). This 
causes the transmission of this SI's information about the negative functional operator to be closed and 
encapsulated by the first. 
 “In 2007, biotechnological crops were a very important milestone with humanitarian 
consequences: for the first time, there were more than 10 million poor small farmers who 
benefited from these kinds of crops in developing countries” (James 2007:5) 
 
These words by Clive James are a clear example of our assertion. The increase of production of 
biotechnological organisms is always positive and has a great impact on humanity because “developing” 
countries have the opportunity to improve their current situation. For this reason, in this SI it is common 
to see the use terms such as “opportunity,” “occasion” or “possibility” referring to the use of 
bio-technologies (or their products). They use a vassalage rhetoric because the biotechnological products 
(that is, of the countries in the system's center) offer them a new means of escaping from their current 
situation. When presented with such a chance, the vassals have the “opportunity,” “occasion” or 
“possibility” to use and apply these products and activities to escape from the “underdeveloped” 
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situation in which they find themselves. 
There has been no developmentalist discourse of biotechnology during the first stages of the debate 
about biotechnology's suitability. The above-mentioned rhetoric has come about as a reply to the 
biodiversity SI and the initial security SI (which is currently more business oriented) and it is accepted 
by experts. In fact, José Félix Tezanos shows that, thanks to the Delphi 2005 studies, where 51 experts in 
human genetics and biotechnology responded to 135 questionnaires, we can see that the experts think 
that scientific-technological innovations have the power to reduce hunger in the world—however, this 
also implies a greater international dependence and increases the north/south gap (Tezanos, 2007). At 
this point, it is important to remember the words of García Canclini (2006) in his work Different, unequal 
and disconnected where he says that:  
 “[…] the illusion of being completely free, that we could change national identity, class and 
gender, made easier by anonymity and distance in virtual interactions evaporates when our 
ethnic aspects or our gestures make visible the history of belonging to one country or the 
other guarded customs of contemporary societies. It must be made clear that practices are not 
mere implementation of the habitus produced by family and school education, through the 
internalization of social norms. When practiced, they become actions, the dispositions of the 
habitus, which have found the best conditions in which to be implemented and, maybe, go on 
beyond mere repetition ” (García Canclini, 2006: 158). 
 
The words of Néstor García Canclini (2006), a clear reference to Pierre Bourdieu (1984) show us that, 
in a way, in spite of the fact that the underdevelopment SI demonstrates the ability to bring about 
transformations in the most impoverished regions (transformations which, it must not be forgotten, also 
imply an identity change beginning when they begin to employ the “western” techno-scientific activity), 
in their own identities, the “belongings on a frontier” cause a transcendence of what we could call as the 
biotechnological habitus. Therefore, either we take the processes of inner transformation or we fall into 
an attempted process of “identity cloning” or assumption of neocolonialism by means of the 
biotechnological activity increasing the transnational dependence processes, as well as a loss of their 
own techno-scientific identity. 
At this point, we must keep in mind the fact that the discourse of the techno-scientific core  implicitly 
contains a mythologization process of its activity. Hence, the techno-science transmits an SI that rejects 
any other non-techno-scientific knowledge because, on grounds of that myth, this knowledge is the only 
Truth possessor (Coca, 2009 and 2010). This is how the truth mythologization process of the inherent 
activity and the conditioned techno-scientific products is created, as well as by the existence of the other 
great modern myth: The pacifying market myth. 
The spread of this group of myths ended up binding together a symbology that later turned into stories. 
This is where the main problem is because these stories ended up as the bedside book of those who 
defended the -ism and, therefore, became the pillar which supported this society (Valero and Coca, 2009: 
235). For this reason, it is possible to prove that most of the techno-scientific agents take the -ism of the 
technoscientifism by setting up their own identity as system agents. In this myth of the techno-scientific 
truth, the aspects positivist paradigm held (neutrality, objectivity and progression) became more 
important. This myth permeated in a centripetal way (center → periphery) and is now held as their own 
by the system's peripheral regions, which, in a identity legitimization process, made it absolute and 
conceived it as the only way out, which allowed them to get out of the social and economic situation in 
which they found themselves. 
However, the techno-scientific system is developed in a way that it sets up its later evolutions in 
previous techno-scientific foundations. For this reason, the regions with a greater biotechnological 
implementation are gradually distancing themselves from the rest. This is due to: 1) the lock process 
inherent to industrial patents, which, far from practicing a common policy of knowledge, searches for 
epistemic isolation, and 2) the fact that the new techno-science is extremely expensive, which creates a 
large economic filter, and thus  not allowing the regions with lower GDP (Gross Domestic Product) to 
have good access to biotechnology. 
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All this is creating a sort of techno-scientific neocolonialism based on the knowledge and the devices 
used to implement it. This process is undertaken by the neo-colonized when they find that 
techno-scientific progress is linear and can only be carried out in one way. However, techno-scientific 
development fulfills a certain function within the social project where it is inscribed (Cohen, 2006). This 
is why there is a possibility to “walk” in a development path different to the current capitalist 
techno-scientist system. The question would be, then, to know the risks of taking that option. 
In the Iberian American context, which is the object of this paper, most of the States in this region 
develop their techno-scientific activities using technologies, devices and knowledge coming from 
countries which are in the “center” of the techno-scientific system. In this context imagineries of the 
scientists are very important. They insist that they intend to produce contributions to social progress, and 
that their research methods are themselves value neutral. Thus, nothing that they do as scientists could be 
responsible for blocking social progress (Harding 2006: 2). Moreover, the scientific progress is 
determinate and inevitable, and is based in a new colonial proccess. 
This new colonial process (postcolonial) has as a target maintaining the control of the 
biotechnological sector by establishing clear gaps between the center and the periphery, or between the 
north and the south of the planet, if that is what we prefer. This does not mean that periphery or 
semi-periphery regions, such as Iberian America, cannot take steps toward the acquisition of new 
biotechnological devices and improvements. What we try to assert here is that, in spite of everything, the 
differences between the center and the periphery will increase unless the less bio-technologically 
developed regions make a tremendous economic, social and educative effort to escape from the situation. 
However, we think that there are many uncertainties regarding this topic, as it has recently occurred in 
Spain, since the techno-scientific system is weak and not very socially consolidated, in an economic 
crisis like the current one, the budget items for this system are reduced, causing a techno-scientific 
involution. 
Finally and as a consequence of taking as own the myth of the pacifying market, Iberian American 
societies bet on a “cloned” biotechnological sector. In this system the unification of company-university 
is not altered. On the contrary, it is seen as the functional mechanism for implementing the 
techno-scientific system of this region. However, internalizing this techno-scientific configuration 
favors even more the situation of (semi)dependence. This is due to the fact that the Iberian American 
spin-off's only target will be developing a biotechnological device with marketability and that, therefore, 
will not be focused on majority interests whose target group has a low- or medium-high economic level. 
For this reason and in order to minimize costs, they will resort to biotechnological devices developed by 
other corporations placed in the center of the system and will target the development and implementation 
of biotechnological products which, to a greater extent, have previously begun in other regions. 
All this allows us to conclude that the current development of the techno-scientific system, taking 
biotechnology as an example, will maintain the gap and may even increase it. It will be necessary to keep 
researching and studying how the system evolves and to try to establish social engineering mechanisms 
(Dagnino & Thomas, 1999) that transform the system, correcting the mistakes. If we accept this, we will 
feel obliged to disregard a non-interventionist social system conception, but this idea will be developed 
in later works. 
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